Meissner B - Search Results

1

Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records.

Rosenman MB, Baker L, Jing Y, Makenbaeva D, Meissner B, Simon TA, Wiederkehr D, Deitelzweig S. Rosenman MB, et al. Among authors: meissner b. Curr Med Res Opin. 2012 Sep;28(9):1407-14. doi: 10.1185/03007995.2012.708653. Epub 2012 Jul 26. Curr Med Res Opin. 2012. PMID: 22746356 Review.

2

Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.

An J, Niu F, Lang DT, Jazdzewski KP, Le PT, Rashid N, Meissner B, Mendes R, Dills DG, Aranda G, Bruno A. An J, et al. Among authors: meissner b. J Am Heart Assoc. 2015 Jul 17;4(7):e001921. doi: 10.1161/JAHA.115.001921. J Am Heart Assoc. 2015. PMID: 26187996 Free PMC article.

3

Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting.

Meissner B, Trivedi D, You M, Rosenblatt L. Meissner B, et al. J Med Econ. 2014 Apr;17(4):259-65. doi: 10.3111/13696998.2014.893241. Epub 2014 Feb 27. J Med Econ. 2014. PMID: 24575891 Free article.

4

Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization.

Meissner B, Dickson M, Shinogle J, Reeder CE, Belazi D, Senevirante V. Meissner B, et al. J Manag Care Pharm. 2006 May;12(4):331-40. doi: 10.18553/jmcp.2006.12.4.331. J Manag Care Pharm. 2006. PMID: 16792439 Free PMC article.

5

Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.

Meissner BL, Moore WM, Shinogle JA, Reeder CE, Little JM. Meissner BL, et al. J Manag Care Pharm. 2004 May-Jun;10(3):226-33. doi: 10.18553/jmcp.2004.10.3.226. J Manag Care Pharm. 2004. PMID: 15228372 Free PMC article.

6

Predicting the impact of Medicare Part D implementation on the pharmacy workforce.

Meissner B, Harrison D, Carter J, Borrego M. Meissner B, et al. Res Social Adm Pharm. 2006 Sep;2(3):315-28. doi: 10.1016/j.sapharm.2006.07.007. Res Social Adm Pharm. 2006. PMID: 17138517

7

Impact of a co-pay accumulator adjustment program on specialty drug adherence.

Sherman BW, Epstein AJ, Meissner B, Mittal M. Sherman BW, et al. Among authors: meissner b. Am J Manag Care. 2019 Jul;25(7):335-340. Am J Manag Care. 2019. PMID: 31318506 Free article.

8

Direct economic effect following mupirocin therapy failure among patients with uncomplicated skin and skin-structure infections in a large population-based cohort.

Meissner B, Burch SP, Sarnes M, Green C, Dalessandro M, Cantrell CR. Meissner B, et al. Manag Care Interface. 2007 Jul;20(7):35-9. Manag Care Interface. 2007. PMID: 17849732

9

Probing chromatin accessibility with small molecule DNA intercalation and nanopore sequencing.

Bai G, Dhillon N, Felton C, Meissner B, Saint-John B, Shelansky R, Meyerson E, Hrabeta-Robinson E, Hodjat B, Boeger H, Brooks AN. Bai G, et al. Among authors: meissner b. bioRxiv [Preprint]. 2024 Mar 22:2024.03.20.585815. doi: 10.1101/2024.03.20.585815. bioRxiv. 2024. PMID: 38562899 Free PMC article. Preprint.

10

Finding a balance in reduced toxicity hematopoietic stem cell transplantation for thalassemia: role of infused CD3+ cell count and immunosuppression.

Meissner B, Lang P, Bader P, Hoenig M, Müller I, Meisel R, Greil J, Sauer MG, Metzler M, Corbacioglu S, Burkhardt B, Wölfl M, Strahm B, Kafa K, Basu O, Lode HN, Gruhn B, Cario H, Ozga AK, Zimmermann M, Jarisch A, Beier R. Meissner B, et al. Bone Marrow Transplant. 2024 Feb 7. doi: 10.1038/s41409-024-02219-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38326567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page